Albendazole for lymphatic filariasis.
Identifieur interne : 003949 ( PubMed/Checkpoint ); précédent : 003948; suivant : 003950Albendazole for lymphatic filariasis.
Auteurs : Julia Critchley [Royaume-Uni] ; D. Addiss ; C. Gamble ; P. Garner ; H. Gelband ; H. EjereSource :
- The Cochrane database of systematic reviews [ 1469-493X ] ; 2005.
Descripteurs français
- KwdFr :
- MESH :
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Albendazole, Diéthylcarbamazine, Filaricides, Ivermectine.
- Association de médicaments, Essais contrôlés randomisés comme sujet, Humains.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Albendazole, Diethylcarbamazine, Filaricides, Ivermectin.
- drug therapy : Elephantiasis, Filarial.
- Drug Therapy, Combination, Humans, Randomized Controlled Trials as Topic.
Abstract
Mass treatment with albendazole co-administered with another antifilarial drug is part of a global programme to eliminate lymphatic filariasis. We sought reliable evidence of the effects of albendazole on the disease and the parasite.
DOI: 10.1002/14651858.CD003753.pub3
PubMed: 16235339
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:16235339Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Albendazole for lymphatic filariasis.</title><author><name sortKey="Critchley, Julia" sort="Critchley, Julia" uniqKey="Critchley J" first="Julia" last="Critchley">Julia Critchley</name><affiliation wicri:level="1"><nlm:affiliation>Liverpool School of Tropical Medicine, International Health Research Group, Pembroke Place, Liverpool, Merseyside, UK L3 5QA. juliac@liv.ac.uk</nlm:affiliation><country>Royaume-Uni</country><wicri:regionArea>Liverpool School of Tropical Medicine, International Health Research Group, Pembroke Place, Liverpool, Merseyside</wicri:regionArea><wicri:noRegion>Merseyside</wicri:noRegion></affiliation></author><author><name sortKey="Addiss, D" sort="Addiss, D" uniqKey="Addiss D" first="D" last="Addiss">D. Addiss</name></author><author><name sortKey="Gamble, C" sort="Gamble, C" uniqKey="Gamble C" first="C" last="Gamble">C. Gamble</name></author><author><name sortKey="Garner, P" sort="Garner, P" uniqKey="Garner P" first="P" last="Garner">P. Garner</name></author><author><name sortKey="Gelband, H" sort="Gelband, H" uniqKey="Gelband H" first="H" last="Gelband">H. Gelband</name></author><author><name sortKey="Ejere, H" sort="Ejere, H" uniqKey="Ejere H" first="H" last="Ejere">H. Ejere</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:16235339</idno><idno type="pmid">16235339</idno><idno type="doi">10.1002/14651858.CD003753.pub3</idno><idno type="wicri:Area/PubMed/Corpus">003B72</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003B72</idno><idno type="wicri:Area/PubMed/Curation">003B72</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003B72</idno><idno type="wicri:Area/PubMed/Checkpoint">003B72</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003B72</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Albendazole for lymphatic filariasis.</title><author><name sortKey="Critchley, Julia" sort="Critchley, Julia" uniqKey="Critchley J" first="Julia" last="Critchley">Julia Critchley</name><affiliation wicri:level="1"><nlm:affiliation>Liverpool School of Tropical Medicine, International Health Research Group, Pembroke Place, Liverpool, Merseyside, UK L3 5QA. juliac@liv.ac.uk</nlm:affiliation><country>Royaume-Uni</country><wicri:regionArea>Liverpool School of Tropical Medicine, International Health Research Group, Pembroke Place, Liverpool, Merseyside</wicri:regionArea><wicri:noRegion>Merseyside</wicri:noRegion></affiliation></author><author><name sortKey="Addiss, D" sort="Addiss, D" uniqKey="Addiss D" first="D" last="Addiss">D. Addiss</name></author><author><name sortKey="Gamble, C" sort="Gamble, C" uniqKey="Gamble C" first="C" last="Gamble">C. Gamble</name></author><author><name sortKey="Garner, P" sort="Garner, P" uniqKey="Garner P" first="P" last="Garner">P. Garner</name></author><author><name sortKey="Gelband, H" sort="Gelband, H" uniqKey="Gelband H" first="H" last="Gelband">H. Gelband</name></author><author><name sortKey="Ejere, H" sort="Ejere, H" uniqKey="Ejere H" first="H" last="Ejere">H. Ejere</name></author></analytic><series><title level="j">The Cochrane database of systematic reviews</title><idno type="eISSN">1469-493X</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Albendazole (therapeutic use)</term><term>Diethylcarbamazine (therapeutic use)</term><term>Drug Therapy, Combination</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Filaricides (therapeutic use)</term><term>Humans</term><term>Ivermectin (therapeutic use)</term><term>Randomized Controlled Trials as Topic</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Albendazole (usage thérapeutique)</term><term>Association de médicaments</term><term>Diéthylcarbamazine (usage thérapeutique)</term><term>Essais contrôlés randomisés comme sujet</term><term>Filaricides (usage thérapeutique)</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Humains</term><term>Ivermectine (usage thérapeutique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Albendazole</term><term>Diethylcarbamazine</term><term>Filaricides</term><term>Ivermectin</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Albendazole</term><term>Diéthylcarbamazine</term><term>Filaricides</term><term>Ivermectine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Drug Therapy, Combination</term><term>Humans</term><term>Randomized Controlled Trials as Topic</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Association de médicaments</term><term>Essais contrôlés randomisés comme sujet</term><term>Humains</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Mass treatment with albendazole co-administered with another antifilarial drug is part of a global programme to eliminate lymphatic filariasis. We sought reliable evidence of the effects of albendazole on the disease and the parasite.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16235339</PMID><DateCreated><Year>2005</Year><Month>10</Month><Day>19</Day></DateCreated><DateCompleted><Year>2006</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Issue>4</Issue><PubDate><Year>2005</Year><Month>Oct</Month><Day>19</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Albendazole for lymphatic filariasis.</ArticleTitle><Pagination><MedlinePgn>CD003753</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Mass treatment with albendazole co-administered with another antifilarial drug is part of a global programme to eliminate lymphatic filariasis. We sought reliable evidence of the effects of albendazole on the disease and the parasite.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To summarize the effects of albendazole alone or in combination with antifilarial drugs for clinical treatment and community control of lymphatic filariasis.</AbstractText><AbstractText Label="SEARCH STRATEGY" NlmCategory="METHODS">We searched the Cochrane Infectious Diseases Group Specialized Register (August 2005), CENTRAL (The Cochrane Library Issue 3, 2005), MEDLINE (1966 to August 2005), EMBASE (1974 to August 2005), LILACS (1982 to August 2005), and reference lists. We also contacted researchers, the World Health Organization, and GlaxoSmithKline.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">Randomized and quasi-randomized controlled trials of albendazole alone or combined with another antifilarial drug for treating individuals with lymphatic filariasis, or for reducing transmission in endemic communities.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">Two authors independently assessed eligibility and trial quality, and extracted data. Authors contacted investigators for missing information or clarification.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">Seven trials including 6997 participants (995 with detectable microfilariae) met the criteria. A comparison of albendazole and placebo detected no effect on microfilariae prevalence (920 participants; 3 trials); one trial (499 participants) reported significantly lower microfilariae density at six months. Albendazole performed slightly worse than ivermectin in two trials (436 participants). Compared with diethylcarbamazine (DEC), two small trials (56 participants) found little difference in microfilariae prevalence over an extended follow up. One larger trial (502 participants) found a statistically significant effect for DEC at six months, but none at three months. Microfilariae prevalence and density were statistically significantly lower with the combination of albendazole and ivermectin compared with ivermectin alone in two of three trials (649 participants). Two trials compared albendazole plus DEC with DEC alone and found no statistically significant difference in microfilariae prevalence, though one trial favoured the combination at six months (relative risk 0.62, 95% confidence interval 0.32 to 1.21; 491 participants). This trial also found a statistically significant reduction in microfilariae density.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">There is insufficient evidence to confirm or refute that albendazole co-administered with DEC or ivermectin is more effective than DEC or ivermectin alone in clearing microfilariae or killing adult worms. Albendazole combined with ivermectin appears to have a small effect on microfilaraemia, but this was not consistently demonstrated. The effect of albendazole against adult and larval filarial parasites, alone and in combination with other antifilarial drugs, deserves further rigorous research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Critchley</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Liverpool School of Tropical Medicine, International Health Research Group, Pembroke Place, Liverpool, Merseyside, UK L3 5QA. juliac@liv.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Addiss</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Gamble</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Garner</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Gelband</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Ejere</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><CollectiveName>International Filariasis Review Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2005</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005369">Filaricides</NameOfSubstance></Chemical><Chemical><RegistryNumber>70288-86-7</RegistryNumber><NameOfSubstance UI="D007559">Ivermectin</NameOfSubstance></Chemical><Chemical><RegistryNumber>F4216019LN</RegistryNumber><NameOfSubstance UI="D015766">Albendazole</NameOfSubstance></Chemical><Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber><NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Cochrane Database Syst Rev. 2004;(1):CD003753</RefSource><PMID Version="1">14974034</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015766" MajorTopicYN="N">Albendazole</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007559" MajorTopicYN="N">Ivermectin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>56</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>10</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>2</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>10</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16235339</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD003753.pub3</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Royaume-Uni</li></country></list><tree><noCountry><name sortKey="Addiss, D" sort="Addiss, D" uniqKey="Addiss D" first="D" last="Addiss">D. Addiss</name><name sortKey="Ejere, H" sort="Ejere, H" uniqKey="Ejere H" first="H" last="Ejere">H. Ejere</name><name sortKey="Gamble, C" sort="Gamble, C" uniqKey="Gamble C" first="C" last="Gamble">C. Gamble</name><name sortKey="Garner, P" sort="Garner, P" uniqKey="Garner P" first="P" last="Garner">P. Garner</name><name sortKey="Gelband, H" sort="Gelband, H" uniqKey="Gelband H" first="H" last="Gelband">H. Gelband</name></noCountry><country name="Royaume-Uni"><noRegion><name sortKey="Critchley, Julia" sort="Critchley, Julia" uniqKey="Critchley J" first="Julia" last="Critchley">Julia Critchley</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003949 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 003949 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:16235339
|texte= Albendazole for lymphatic filariasis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:16235339" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |